Besides, our further study found that PD-1 on CD8+ T cells was generally expressed higher in PB and BM from de novo and relapse-refractory AML patients, while it was partially recovered in complete remission patients (36). The gene discussed is CD8A; the disease is acute myeloid leukemia.